🏥 Attention healthcare professionals! Our new blog post dissects the latest advancements in brain tumour diagnostics. Explore 10 game-changing technologies that are revolutionizing patient care. Stay at the forefront of your field – read now and elevate your practice! 👉 https://bit.ly/3Xzwfuy #BrainHealth #MedicalInnovation #BrainTumourAwareness #PatientEmpowerment #HealthEducation #Sanux
Cyril De La Torre’s Post
More Relevant Posts
-
🏥 Attention healthcare professionals! Our new blog post dissects the latest advancements in brain tumour diagnostics. Explore 10 game-changing technologies that are revolutionizing patient care. Stay at the forefront of your field – read now and elevate your practice! 👉 https://bit.ly/3Xzwfuy #BrainHealth #MedicalInnovation #BrainTumourAwareness #PatientEmpowerment #HealthEducation #Sanux
-
-
🏥 Attention healthcare professionals! Our new blog post dissects the latest advancements in brain tumour diagnostics. Explore 10 game-changing technologies that are revolutionizing patient care. Stay at the forefront of your field – read now and elevate your practice! 👉 https://bit.ly/3Xzwfuy #BrainHealth #MedicalInnovation #BrainTumourAwareness #PatientEmpowerment #HealthEducation #Sanux
-
-
🏥 Attention healthcare professionals! Our new blog post dissects the latest advancements in brain tumour diagnostics. Explore 10 game-changing technologies that are revolutionizing patient care. Stay at the forefront of your field – read now and elevate your practice! 👉 https://bit.ly/3Xzwfuy #BrainHealth #MedicalInnovation #BrainTumourAwareness #PatientEmpowerment #HealthEducation #Sanux
-
-
🩺 Q&A with Dr. Peter Ford 🔬 Discover how minimally invasive procedures are transforming vein treatments! Dr. Ford explains why these "walk in, walk out" options are a game-changer for patients. Watch now to learn about the biggest breakthrough in modern vascular medicine! #LegVeinCare #MedicalInnovation #TheLegVeinExperts
-
Passionate about internal communication, education administration, compliance, and event management. Skilled in managing multiple stakeholders and driving team cohesion. Always eager to explore new challenges
In the latest Vivid Magazine, GE HealthCare explores the prognostic value of myocardial work. Dr. Jing Yao explains how she’s applying the method to make clinical decisions about Cardiac Resynchronization Therapy. Dive in today! #Vivid #VividMagazine #myocardialwork #CRT #echocardiography #GEHealthCare #CardiovascularUltrasound #CardiovascularHealth #Ultrasound #HeartHealth
-
In the latest Vivid Magazine, GE HealthCare explores the prognostic value of myocardial work. Dr. Jing Yao explains how she’s applying the method to make clinical decisions about Cardiac Resynchronization Therapy. Dive in today! #Vivid #VividMagazine #myocardialwork #CRT #echocardiography #GEHealthCare #CardiovascularUltrasound #CardiovascularHealth #Ultrasound #HeartHealth
Could myocardial work help predict CRT outcomes with Dr. Jing Yao | Vivid Magazine Edition 4
gehealthcare.smh.re
-
In the latest Vivid Magazine, GE HealthCare explores the prognostic value of myocardial work. Dr. Jing Yao explains how she’s applying the method to make clinical decisions about Cardiac Resynchronization Therapy. Dive in today! #Vivid #VividMagazine #myocardialwork #CRT #echocardiography #GEHealthCare #CardiovascularUltrasound #CardiovascularHealth #Ultrasound #HeartHealth
Could myocardial work help predict CRT outcomes with Dr. Jing Yao | Vivid Magazine Edition 4
gehealthcare.smh.re
-
🧠 Viz.ai, NICO Corporation collaborate on improving intracerebral hemorrhage outcomes The collaboration will use Viz.ai’s technology that enables hospitals to detect the disease earlier and get accurate measurements of brain bleeds which are essential for determining the severity of cases. It will also leverage NICO Corporation’s technology that provides early and safe access to the brain with its BrainPath solution and maximal evacuation of the clot with the Myriad solution. The combination of technologies from both companies will facilitate broader efficiencies and enhance patient care. Viz.ai CEO and co-founder Dr Chris Mansi said: “The results of the ENRICH trial have finally shown positive treatment data on one of the most costly and deadly diseases. “We’re excited to collaborate with NICO, leveraging our broadly deployed AI platform to assist neurosurgeons in their decision-making and improve patient outcomes post intracerebral haemorrhage.” Intracerebral haemorrhage (ICH), caused by bleeding within the brain tissue, is a life-threatening type of stroke, accounts for up to 15% of all strokes, and has high morbidity and mortality rates. Read more online: https://lnkd.in/eUmcyxKq 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #vizai #nicocorporation #strokecare
-
-
In the latest Vivid Magazine, GE HealthCare explores the prognostic value of myocardial work. Dr. Jing Yao explains how she’s applying the method to make clinical decisions about Cardiac Resynchronization Therapy. Dive in today! #Vivid #VividMagazine #myocardialwork #CRT #echocardiography #GEHealthCare #CardiovascularUltrasound #CardiovascularHealth #Ultrasound #HeartHealth
Could myocardial work help predict CRT outcomes with Dr. Jing Yao | Vivid Magazine Edition 4
gehealthcare.smh.re
-
In the latest Vivid Magazine, GE HealthCare explores the prognostic value of myocardial work. Dr. Jing Yao explains how she’s applying the method to make clinical decisions about Cardiac Resynchronization Therapy. Dive in today! #Vivid #VividMagazine #myocardialwork #CRT #echocardiography #GEHealthCare #CardiovascularUltrasound #CardiovascularHealth #Ultrasound #HeartHealth
Could myocardial work help predict CRT outcomes with Dr. Jing Yao | Vivid Magazine Edition 4
